Molecular insights into GPCR mechanisms for drugs of abuse
- PMID: 37599003
- PMCID: PMC10514560
- DOI: 10.1016/j.jbc.2023.105176
Molecular insights into GPCR mechanisms for drugs of abuse
Abstract
Substance abuse is on the rise, and while many people may use illicit drugs mainly due to their rewarding effects, their societal impact can range from severe, as is the case for opioids, to promising, as is the case for psychedelics. Common with all these drugs' mechanisms of action are G protein-coupled receptors (GPCRs), which lie at the center of how these drugs mediate inebriation, lethality, and therapeutic effects. Opioids like fentanyl, cannabinoids like tetrahydrocannabinol, and psychedelics like lysergic acid diethylamide all directly bind to GPCRs to initiate signaling which elicits their physiological actions. We herein review recent structural studies and provide insights into the molecular mechanisms of opioids, cannabinoids, and psychedelics at their respective GPCR subtypes. We further discuss how such mechanistic insights facilitate drug discovery, either toward the development of novel therapies to combat drug abuse or toward harnessing therapeutic potential.
Keywords: GPCR; cannabinoid; drugs of abuse; opioid; pharmacology; serotonin; structure.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest D. W. has consulted for Otsuka Pharmaceutical, Longboard Pharmaceuticals and Ocean Bio Ltd on the design of psychedelic-based therapeutics. None of the companies listed herein contributed to the funding or narrative of the manuscript. The other authors declare that they have no conflicts of interest with the contents of this article.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10514560/bin/gr1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10514560/bin/gr2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10514560/bin/gr3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10514560/bin/gr4.gif)
Similar articles
-
Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.Prog Mol Biol Transl Sci. 2013;117:207-65. doi: 10.1016/B978-0-12-386931-9.00009-X. Prog Mol Biol Transl Sci. 2013. PMID: 23663971 Free PMC article. Review.
-
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).Psychopharmacology (Berl). 2019 Feb;236(2):799-808. doi: 10.1007/s00213-018-5055-9. Epub 2018 Oct 8. Psychopharmacology (Berl). 2019. PMID: 30298278 Free PMC article.
-
Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.AAPS J. 2006 Jan 6;7(4):E871-84. doi: 10.1208/aapsj070485. AAPS J. 2006. PMID: 16594640 Free PMC article. Review.
-
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.Curr Top Behav Neurosci. 2018;36:45-73. doi: 10.1007/7854_2017_478. Curr Top Behav Neurosci. 2018. PMID: 28677096 Free PMC article. Review.
-
β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.Handb Exp Pharmacol. 2014;219:427-43. doi: 10.1007/978-3-642-41199-1_22. Handb Exp Pharmacol. 2014. PMID: 24292843 Free PMC article. Review.
Cited by
-
Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT1eR and 5-HT1FR.Sci Adv. 2024 Apr 19;10(16):eadk4855. doi: 10.1126/sciadv.adk4855. Epub 2024 Apr 17. Sci Adv. 2024. PMID: 38630816 Free PMC article.
-
Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR.bioRxiv [Preprint]. 2023 Oct 7:2023.10.05.561100. doi: 10.1101/2023.10.05.561100. bioRxiv. 2023. Update in: Sci Adv. 2024 Apr 19;10(16):eadk4855. doi: 10.1126/sciadv.adk4855. PMID: 37986777 Free PMC article. Updated. Preprint.
References
-
- Miech R.A., Johnston L.D., Patrick M.E., O'Malley P.M., Bachman J.G., Schulenberg J.E. Ann Arbor, MI; Institute for Social Research University of Michigan: 2023. Monitoring the Future national survey results on drug use, 1975-2022: Secondary school students. Monitoring the Future Monograph Series.
-
- Spencer M.R., Miniño A.M., Warner M. National Center for Health Statistics; Hyattsville, MD: 2022. Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief, no 457. - PubMed
-
- Statistics N.C.f.H., editor. Wide-ranging online data for epidemiologic research (WONDER) Atlanta, GA; National Center for Health Statistics: 2022.
-
- Zhuang Y., Wang Y., He B., He X., Zhou X.E., Guo S., et al. Molecular recognition of morphine and fentanyl by the human mu-opioid receptor. Cell. 2022;185:4361–4375.e19. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources